Rheumatoid Arthritis Diagnostic Tests Market, By Test Type (Serology Test (Erythrocyte Sedimentation Rate (ESR), Rheumatoid Factor (RF), Anti-cyclic Citrullinated Peptide (anti-CCP), Antinuclear Antibody (ANA), Uric Acid, Other Tests), Monitoring RA Treat
Description
Rheumatoid Arthritis Diagnostic Tests Market, By Test Type (Serology Test (Erythrocyte Sedimentation Rate (ESR), Rheumatoid Factor (RF), Anti-cyclic Citrullinated Peptide (anti-CCP), Antinuclear Antibody (ANA), Uric Acid, Other Tests), Monitoring RA Treatment Efficiency Tests (Salicylate Level Count, Muscle Enzyme Tests (CPK, Aldolase), Creatinine Test)), By End User (Diagnostic Laboratories, Private Laboratories, Public Laboratories, Ambulatory Surgical Centers), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028
Rheumatoid Arthritis is an autoimmune disease which leads joint pain due to inflammation of joint lining. The condition usually affects the hands, feet and wrists. Blood tests commonly used to diagnose RA include, rheumatoid factor anti-cyclic citrullinated peptide, C - reactive protein (CRP), and Erythrocyte Sedimentation Rate (ESR). Increasing prevalence of RA is expected to propel growth of the global rheumatoid arthritis diagnostic tests market over the forecast period. Furthermore, development of new blood tests for RA is also expected to propel growth of the global rheumatoid arthritis diagnostic tests market over the forecast period
Key features of the study:
This report provides in-depth analysis of the Rheumatoid Arthritis Diagnostic Tests market and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
It profiles key players in the global Rheumatoid Arthritis Diagnostic Tests market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include, Abbott Diagnostics (Abbott Laboratories), Antibodies Inc., Beckman Coulter, Inc., Euro Diagnostica AB, F. Hoffmann-La Roche Ltd., Qiagen NV, Siemens Healthcare GmbH, and Thermo Fisher Scientific Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
The global Rheumatoid Arthritis Diagnostic Tests market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Rheumatoid Arthritis Diagnostic Tests market
Detailed Segmentation:
Rheumatoid Arthritis Diagnostic Tests Market, By Test Type:
Serology Test
Erythrocyte Sedimentation Rate (ESR)
Rheumatoid Factor (RF)
Anti-cyclic Citrullinated Peptide (anti-CCP)
Antinuclear Antibody (ANA)
Uric Acid
Other Tests
Monitoring RA Treatment Efficiency Tests
Salicylate Level Count
Muscle Enzyme Tests (CPK, Aldolase)
Creatinine Test
Rheumatoid Arthritis Diagnostic Tests Market, By End User:
Diagnostic Laboratories
Private Laboratories
Public Laboratories
Ambulatory Surgical Centers
Rheumatoid Arthritis Diagnostic Tests Market, By Region:
North America
By Test Type:
Serology Test
Erythrocyte Sedimentation Rate (ESR)
Rheumatoid Factor (RF)
Anti-cyclic Citrullinated Peptide (anti-CCP)
Antinuclear Antibody (ANA)
Uric Acid
Other Tests
Monitoring RA Treatment Efficiency Tests
Salicylate Level Count
Muscle Enzyme Tests (CPK, Aldolase)
Creatinine Test
By End User
Diagnostic Laboratories
Private Laboratories
Public Laboratories
Ambulatory Surgical Centers
By Country:
U.S.
Canada
Latin America
By Test Type:
Serology Test
Erythrocyte Sedimentation Rate (ESR)
Rheumatoid Factor (RF)
Anti-cyclic Citrullinated Peptide (anti-CCP)
Antinuclear Antibody (ANA)
Uric Acid
Other Tests
Monitoring RA Treatment Efficiency Tests
Salicylate Level Count
Muscle Enzyme Tests (CPK, Aldolase)
Creatinine Test
By End User
Diagnostic Laboratories
Private Laboratories
Public Laboratories
Ambulatory Surgical Centers
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Test Type:
Serology Test
Erythrocyte Sedimentation Rate (ESR)
Rheumatoid Factor (RF)
Anti-cyclic Citrullinated Peptide (anti-CCP)
Antinuclear Antibody (ANA)
Uric Acid
Other Tests
Monitoring RA Treatment Efficiency Tests
Salicylate Level Count
Muscle Enzyme Tests (CPK, Aldolase)
Creatinine Test
By End User
Diagnostic Laboratories
Private Laboratories
Public Laboratories
Ambulatory Surgical Centers
By Country:
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
By Test Type:
Serology Test
Erythrocyte Sedimentation Rate (ESR)
Rheumatoid Factor (RF)
Anti-cyclic Citrullinated Peptide (anti-CCP)
Antinuclear Antibody (ANA)
Uric Acid
Other Tests
Monitoring RA Treatment Efficiency Tests
Salicylate Level Count
Muscle Enzyme Tests (CPK, Aldolase)
Creatinine Test
By End User
Diagnostic Laboratories
Private Laboratories
Public Laboratories
Ambulatory Surgical Centers
By Country:
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Test Type:
Serology Test
Erythrocyte Sedimentation Rate (ESR)
Rheumatoid Factor (RF)
Anti-cyclic Citrullinated Peptide (anti-CCP)
Antinuclear Antibody (ANA)
Uric Acid
Other Tests
Monitoring RA Treatment Efficiency Tests
Salicylate Level Count
Muscle Enzyme Tests (CPK, Aldolase)
Creatinine Test
By End User
Diagnostic Laboratories
Private Laboratories
Public Laboratories
Ambulatory Surgical Centers
By Country:
GCC
Israel
Rest of Middle East
Africa
By Test Type:
Serology Test
Erythrocyte Sedimentation Rate (ESR)
Rheumatoid Factor (RF)
Anti-cyclic Citrullinated Peptide (anti-CCP)
Antinuclear Antibody (ANA)
Uric Acid
Other Tests
Monitoring RA Treatment Efficiency Tests
Salicylate Level Count
Muscle Enzyme Tests (CPK, Aldolase)
Creatinine Test
By End User
Diagnostic Laboratories
Private Laboratories
Public Laboratories
Ambulatory Surgical Centers
By Country:
South Africa
Central Africa
North Africa
Company Profiles
Abbott Diagnostics (Abbott Laboratories) *
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
Antibodies Inc.
Beckman Coulter, Inc.
Euro Diagnostica AB
F. Hoffmann-La Roche Ltd.
Qiagen NV
Siemens Healthcare Gmb
Thermo Fisher Scientific Inc.
“*” marked represents similar segmentation in other categories in the respective section.
Rheumatoid Arthritis is an autoimmune disease which leads joint pain due to inflammation of joint lining. The condition usually affects the hands, feet and wrists. Blood tests commonly used to diagnose RA include, rheumatoid factor anti-cyclic citrullinated peptide, C - reactive protein (CRP), and Erythrocyte Sedimentation Rate (ESR). Increasing prevalence of RA is expected to propel growth of the global rheumatoid arthritis diagnostic tests market over the forecast period. Furthermore, development of new blood tests for RA is also expected to propel growth of the global rheumatoid arthritis diagnostic tests market over the forecast period
Key features of the study:
This report provides in-depth analysis of the Rheumatoid Arthritis Diagnostic Tests market and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
It profiles key players in the global Rheumatoid Arthritis Diagnostic Tests market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include, Abbott Diagnostics (Abbott Laboratories), Antibodies Inc., Beckman Coulter, Inc., Euro Diagnostica AB, F. Hoffmann-La Roche Ltd., Qiagen NV, Siemens Healthcare GmbH, and Thermo Fisher Scientific Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
The global Rheumatoid Arthritis Diagnostic Tests market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Rheumatoid Arthritis Diagnostic Tests market
Detailed Segmentation:
Rheumatoid Arthritis Diagnostic Tests Market, By Test Type:
Serology Test
Erythrocyte Sedimentation Rate (ESR)
Rheumatoid Factor (RF)
Anti-cyclic Citrullinated Peptide (anti-CCP)
Antinuclear Antibody (ANA)
Uric Acid
Other Tests
Monitoring RA Treatment Efficiency Tests
Salicylate Level Count
Muscle Enzyme Tests (CPK, Aldolase)
Creatinine Test
Rheumatoid Arthritis Diagnostic Tests Market, By End User:
Diagnostic Laboratories
Private Laboratories
Public Laboratories
Ambulatory Surgical Centers
Rheumatoid Arthritis Diagnostic Tests Market, By Region:
North America
By Test Type:
Serology Test
Erythrocyte Sedimentation Rate (ESR)
Rheumatoid Factor (RF)
Anti-cyclic Citrullinated Peptide (anti-CCP)
Antinuclear Antibody (ANA)
Uric Acid
Other Tests
Monitoring RA Treatment Efficiency Tests
Salicylate Level Count
Muscle Enzyme Tests (CPK, Aldolase)
Creatinine Test
By End User
Diagnostic Laboratories
Private Laboratories
Public Laboratories
Ambulatory Surgical Centers
By Country:
U.S.
Canada
Latin America
By Test Type:
Serology Test
Erythrocyte Sedimentation Rate (ESR)
Rheumatoid Factor (RF)
Anti-cyclic Citrullinated Peptide (anti-CCP)
Antinuclear Antibody (ANA)
Uric Acid
Other Tests
Monitoring RA Treatment Efficiency Tests
Salicylate Level Count
Muscle Enzyme Tests (CPK, Aldolase)
Creatinine Test
By End User
Diagnostic Laboratories
Private Laboratories
Public Laboratories
Ambulatory Surgical Centers
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Test Type:
Serology Test
Erythrocyte Sedimentation Rate (ESR)
Rheumatoid Factor (RF)
Anti-cyclic Citrullinated Peptide (anti-CCP)
Antinuclear Antibody (ANA)
Uric Acid
Other Tests
Monitoring RA Treatment Efficiency Tests
Salicylate Level Count
Muscle Enzyme Tests (CPK, Aldolase)
Creatinine Test
By End User
Diagnostic Laboratories
Private Laboratories
Public Laboratories
Ambulatory Surgical Centers
By Country:
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
By Test Type:
Serology Test
Erythrocyte Sedimentation Rate (ESR)
Rheumatoid Factor (RF)
Anti-cyclic Citrullinated Peptide (anti-CCP)
Antinuclear Antibody (ANA)
Uric Acid
Other Tests
Monitoring RA Treatment Efficiency Tests
Salicylate Level Count
Muscle Enzyme Tests (CPK, Aldolase)
Creatinine Test
By End User
Diagnostic Laboratories
Private Laboratories
Public Laboratories
Ambulatory Surgical Centers
By Country:
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Test Type:
Serology Test
Erythrocyte Sedimentation Rate (ESR)
Rheumatoid Factor (RF)
Anti-cyclic Citrullinated Peptide (anti-CCP)
Antinuclear Antibody (ANA)
Uric Acid
Other Tests
Monitoring RA Treatment Efficiency Tests
Salicylate Level Count
Muscle Enzyme Tests (CPK, Aldolase)
Creatinine Test
By End User
Diagnostic Laboratories
Private Laboratories
Public Laboratories
Ambulatory Surgical Centers
By Country:
GCC
Israel
Rest of Middle East
Africa
By Test Type:
Serology Test
Erythrocyte Sedimentation Rate (ESR)
Rheumatoid Factor (RF)
Anti-cyclic Citrullinated Peptide (anti-CCP)
Antinuclear Antibody (ANA)
Uric Acid
Other Tests
Monitoring RA Treatment Efficiency Tests
Salicylate Level Count
Muscle Enzyme Tests (CPK, Aldolase)
Creatinine Test
By End User
Diagnostic Laboratories
Private Laboratories
Public Laboratories
Ambulatory Surgical Centers
By Country:
South Africa
Central Africa
North Africa
Company Profiles
Abbott Diagnostics (Abbott Laboratories) *
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
Antibodies Inc.
Beckman Coulter, Inc.
Euro Diagnostica AB
F. Hoffmann-La Roche Ltd.
Qiagen NV
Siemens Healthcare Gmb
Thermo Fisher Scientific Inc.
“*” marked represents similar segmentation in other categories in the respective section.
Table of Contents
165 Pages
- 1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- 2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Test Type
- Market Snippets, By End User
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- 3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Key Highlights
- Product launch
- PEST Analysis
- Technological Advancements
- Regulatory Scenario
- Mergers and Acquisitions
- 4. Rheumatoid Arthritis Diagnostic Tests Market, By Test Type, 2017 - 2028, (US$ Mn)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
- Serology Test
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Erythrocyte Sedimentation Rate (ESR)
- Rheumatoid Factor (RF)
- Anti-cyclic Citrullinated Peptide (anti-CCP)
- Antinuclear Antibody (ANA)
- Uric Acid
- Other Tests
- Monitoring RA Treatment Efficiency Tests
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Salicylate Level Count
- Muscle Enzyme Tests (CPK, Aldolase)
- Creatinine Test
- 5. Rheumatoid Arthritis Diagnostic Tests Market, By End User, 2017 - 2028, (US$ Mn)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
- Hospital
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Private Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Public Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- 6. Rheumatoid Arthritis Diagnostic Tests Market, By Region, 2017 - 2028, (US$ Mn)
- Introduction
- Market Share Analysis, By Region, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, For Regions, 2017 - 2028
- North America
- Market Size and Forecast, By Test Type, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By End User, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
- U.S.
- Canada
- Latin America
- Market Size and Forecast, By Test Type, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By End User, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Market Size and Forecast, By Test Type, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By End User, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Test Type, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By End User, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of APAC
- Middle East
- Market Size and Forecast, By Test Type, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By End User, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Market Size and Forecast, By Test Type, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By End User, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
- South Africa
- Central Africa
- North Africa
- 7. Competitive Landscape
- Company Profiles
- Abbott Diagnostics (Abbott Laboratories)
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Antibodies Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Beckman Coulter, Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Euro Diagnostica AB
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- F. Hoffmann-La Roche Ltd.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Qiagen NV
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Siemens Healthcare GmbH
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Thermo Fisher Scientific Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- 8. Section
- References
- Research Methodology
- About us and Sales Contact
- *Browse 26 market data tables and 18 figures on “Rheumatoid Arthritis Diagnostic Tests Market - Global forecast to 2028”.
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
